Current Eye Drop Recall Overview
The U.S. Food and Drug Administration has confirmed recalls of several eye drop brands linked to contamination and sterility concerns. The most prominent recall involves products distributed by Global Pharma Healthcare, which manufactures artificial tears and lubricating eye drops sold under multiple labels. These recalls expanded after routine testing detected microbial contamination in unopened bottles. Consumers and health professionals are advised to check lot numbers and immediately stop using any affected products. The FDA maintains an updated recall database with searchable product names, NDC codes, and manufacturer details at FDA Recalls and Safety Alerts.
Major retailers and pharmacy chains have removed recalled eye drops from shelves and online listings. Distributors in the United States and international markets received voluntary and, in some cases, mandatory recall requests. The recalls focus on over-the-counter lubricating eye drops marketed for dry eyes, redness relief, and post-surgical care. Reports of eye infections, irritation, and blurred vision tied to contaminated products prompted the agency to issue public warnings. The FDA has also flagged counterfeit and mislabeled eye drop products entering the supply chain through unauthorized sellers.
Brands and Products Affected by the Recall
Global Pharma Healthcare's Artificial Tears Lubricant Eye Drops are among the primary products named in the recall. The company manufactures multiple SKUs distributed under private-label and store-brand names at major retailers and online marketplaces. Affected bottles often list NDC numbers associated with Global Pharma Healthcare and include specific lot numbers printed on the packaging. The recall covers preservative-free and preserved formulations sold in single-use and multi-dose containers. Reports indicate the contamination risk applies to products shipped before certain dates and distributed across multiple states.
Other brands have faced secondary recalls after third-party testing or consumer complaints revealed similar issues. Some products marketed as lubricating eye drops or redness relievers were found to contain non-sterile ingredients or packaging defects that compromise safety. The FDA has linked certain eye drop products to clusters of bacterial and fungal eye infections, including cases requiring medical treatment. Consumers should verify product names, NDC codes, and lot numbers against the agency's recall database before using any eye drops. The agency also advises checking manufacturer websites and contacting retailers directly for confirmation on whether a specific batch is affected.
Health Risks, Consumer Guidance, and Regulatory Actions
Using contaminated eye drops can lead to eye infections, corneal damage, and in severe cases, permanent vision loss. Symptoms reported by users include redness, swelling, discharge, pain, and blurred vision shortly after application. The FDA has received adverse event reports linking specific lot numbers to these clinical outcomes and is coordinating with manufacturers and distributors to trace the supply chain. Patients who have used recalled products and experience any symptoms should seek immediate medical attention and report the issue to the agency.
Regulatory authorities have increased inspections of eye drop manufacturing facilities and tightened sterility testing requirements. The FDA has issued warning letters and initiated enforcement actions against companies failing to meet current good manufacturing practices. Consumers are advised to purchase eye drops only from licensed pharmacies and authorized online sellers, and to avoid products with damaged seals or unclear labeling. For the latest updates on recalls, safety communications, and product testing results, visit the FDA's dedicated eye drop recall page at FDA Recalls and Safety Alerts and review guidance from professional ophthalmology associations at American Academy of Ophthalmology Eye Drop Recall Guidance.